Dhvanit Shah is the founder of Garuda Therapeutics. Garuda Therapeutics has raised $72M in total funding. Latest round: Series A.
Dhvanit Shah, Ph.D., is the co-founder and CEO of Garuda Therapeutics, a biotechnology company focused on revolutionizing blood stem cell transplants. He co-founded the company alongside Kiran Reddy, M.D., David Scadden, M.D., and Sean Morrison, Ph.D. In 2023, he launched the company with $72 million in Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library